Boston Scientific (BSX) Return on Capital Employed (2009 - 2026)
Boston Scientific recorded quarterly Return on Capital Employed of 9.62% in Q1 2026, little changed quarter-over-quarter from 9.57% in Q4 2025, and up 141.0% year-over-year from 3.99% in Q1 2025.
Boston Scientific's Return on Capital Employed history runs 18 years deep, the most recent figure standing at 9.62% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 141.0% year-over-year to 9.62%; the TTM figure through Mar 2026 stood at 9.62% (up 141.0% YoY), while the FY2025 annual figure was 10.01%, up 158.0% from the prior year.
- Return on Capital Employed came in at 9.62% for Q1 2026 at Boston Scientific, roughly flat from 9.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9.62% in Q1 2026 to a low of 4.62% in Q1 2022.
- A 5-year average of 7.4% and a median of 7.9% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed surged 410 bps in 2022 and increased 15 bps in 2024, its largest moves.
- Boston Scientific's Return on Capital Employed stood at 5.81% in 2022, then jumped by 36 bps to 7.9% in 2023, then rose by 2 bps to 8.05% in 2024, then climbed by 19 bps to 9.57% in 2025, then advanced by 0 bps to 9.62% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 9.62%, 9.57%, and 9.41% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.62% |
| Dec 31, 2025 | 9.57% |
| Sep 30, 2025 | 9.41% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | 8.21% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | 7.93% |
| Jun 30, 2024 | 7.89% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | 7.90% |
| Sep 30, 2023 | 7.39% |
| Jun 30, 2023 | 6.37% |
| Mar 31, 2023 | 6.07% |
| Dec 31, 2022 | 5.81% |
| Sep 30, 2022 | 5.00% |
| Jun 30, 2022 | 5.13% |
| Mar 31, 2022 | 4.62% |
| Dec 31, 2021 | 4.32% |
| Sep 30, 2021 | 3.89% |
| Jun 30, 2021 | 1.77% |
| Mar 31, 2021 | 0.52% |
| Dec 31, 2020 | -0.29% |
| Sep 30, 2020 | 0.29% |
| Jun 30, 2020 | 2.44% |
| Mar 31, 2020 | 4.26% |
| Dec 31, 2019 | 6.38% |
| Sep 30, 2019 | 7.65% |
| Jun 30, 2019 | 8.50% |
| Mar 31, 2019 | 9.15% |
| Dec 31, 2018 | 9.76% |
| Sep 30, 2018 | 10.09% |
| Jun 30, 2018 | 10.19% |
| Mar 31, 2018 | 9.39% |
| Dec 31, 2017 | 9.74% |
| Sep 30, 2017 | 8.08% |
| Jun 30, 2017 | 7.77% |
| Mar 31, 2017 | 3.57% |
| Dec 31, 2016 | 3.12% |
| Sep 30, 2016 | 0.54% |
| Jun 30, 2016 | -3.88% |
| Mar 31, 2016 | -0.09% |
| Dec 31, 2015 | -1.80% |
| Sep 30, 2015 | -3.55% |
| Jun 30, 2015 | -1.24% |
| Mar 31, 2015 | -3.31% |
| Dec 31, 2014 | -2.14% |
| Sep 30, 2014 | 2.15% |
| Jun 30, 2014 | 2.44% |
| Mar 31, 2014 | 4.38% |
| Dec 31, 2013 | 0.80% |
| Sep 30, 2013 | 0.73% |
| Jun 30, 2013 | -4.08% |
| Mar 31, 2013 | -28.68% |
| Dec 31, 2012 | -25.36% |
| Sep 30, 2012 | -24.54% |
| Jun 30, 2012 | -17.21% |
| Mar 31, 2012 | 3.97% |
| Dec 31, 2011 | 4.61% |
| Sep 30, 2011 | 5.51% |
| Jun 30, 2011 | 5.82% |
| Mar 31, 2011 | 5.75% |
| Dec 31, 2010 | -3.33% |
| Sep 30, 2010 | -11.29% |
| Jun 30, 2010 | -12.67% |
| Mar 31, 2010 | -11.33% |
| Dec 31, 2009 | -3.94% |
| Sep 30, 2009 | -9.03% |